Key Information
- About us
- Why choose us?
- Our Accreditations
- Key team members
- Serious injury links
- Serious injury case studies
- Serious injury testimonials
The help & support we provide
- Serious injury services
- Serious injury compensation
- Serious injury case process
- Case funding
- Chosen the wrong solicitor?
Further research resources
Osteoporosis drug 'increases atypical fracture risk'RSS Feed
Older women who used bisphosphonates to treat the spinal injury seen in osteoporosis were more likely to experience atypical fractures, research has shown.
A study, published in journal JAMA, found that those who took bisphosphonates for more than five years were more likely to suffer an atypical fracture in the femoral shaft.
According to study authors, around half of women over the age of 50 will sustain an osteoporosis-related fracture and one in five of these patients will die within 12 months.
"Long-term use of these drugs may warrant reconsideration, especially in patients at relatively low risk of fracture. It may be appropriate to consider a drug holiday for selected patients, particularly as the cumulative duration of bisphosphonate therapy surpasses five years," wrote the authors.
This comes after news that a new functional electrical stimulation treatment worked significantly better than occupational therapy at reducing disability in those with spinal injury.
News by Serious Law. Expert legal assistance for those affected by spinal injury
Posted by Timothy Walters
Electrical stimulation 'to help those with spinal injury'
New spinal injury implant designed to encourage bone growth
Hypothermia 'leads to miraculous spinal injury recovery'
To visit our most popular resources click here
